The estimated Net Worth of Stuart M. Grant is at least $6.11 millió dollars as of 2 July 2024. Stuart Grant owns over 1,515,151 units of Eyenovia Inc stock worth over $6,111,926 and over the last 5 years Stuart sold EYEN stock worth over $0.
Stuart has made over 26 trades of the Eyenovia Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Stuart bought 1,515,151 units of EYEN stock worth $1,000,000 on 2 July 2024.
The largest trade Stuart's ever made was buying 1,515,151 units of Eyenovia Inc stock on 2 July 2024 worth over $1,000,000. On average, Stuart trades about 182,535 units every 67 days since 2019. As of 2 July 2024 Stuart still owns at least 10,914,153 units of Eyenovia Inc stock.
You can see the complete history of Stuart Grant stock trades at the bottom of the page.
Stuart's mailing address filed with the SEC is 11 SUMMIT LANE, , GREENVILLE, DE, 19807.
Over the last 7 years, insiders at Eyenovia Inc have traded over $1,275,000 worth of Eyenovia Inc stock and bought 6,072,235 units worth $17,599,075 . The most active insiders traders include Ernest Mario, Stuart M. Grant és Fredric N Eshelman. On average, Eyenovia Inc executives and independent directors trade stock every 31 days with the average trade being worth of $49,678. The most recent stock trade was executed by Michael M Rowe on 28 August 2024, trading 27,071 units of EYEN stock currently worth $14,077.
eyenovia, inc. (nasdaq: eyen) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, presbyopia, mydriasis and other eye diseases.
Eyenovia Inc executives and other stock owners filed with the SEC include: